BIOXTRACT (Public limited company)

BE 0480.174.942 Active ●Zone d'activités Nord 1, 5377 Somme-Leuze

BIOXTRACT is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0480.174.942. It was founded on 08-05-2003. Its registered office is in Somme-Leuze. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 1 054 700 and a profit of € 31 064. These accounts report 0.5 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 09-10-2026.

Company information

Status
Active
Enterprise number
BE 0480.174.942
VAT registered
Yes
Founded
08-05-2003
Latest accounts
2025
Employees
0.5 FTE
Region
Wallonia
Establishments
2
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Zone d'activités Nord 1, 5377 Somme-Leuze
Main activity
Scientific research and development
NACE activities
72109 Recherche-développement en autres sciences physiques et naturelles
46460 Commerce de gros de produits pharmaceutiques et médicaux
47741 Commerce de détail d'articles médicaux et orthopédiques, à l'exception de lunettes de correction, de lentilles et de lunettes de soleil

Key figures of BIOXTRACT

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 31 064-88 %€ 250 780+11 %€ 225 210+1 067 %€ 19 305
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 1 054 700+3 %€ 1 023 635+32 %€ 772 856+41 %€ 547 646
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 092 227-10 %€ 1 210 211+7 %€ 1 130 017+44 %€ 785 024
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 302 252-50 %€ 609 893-3 %€ 627 625+3 %€ 609 665
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
0.5-38 %0.8-47 %1.5-35 %2.3

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
3 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
PNEUMOCARE 5340 Gesves
Education et Management Consultancy 5580 Rochefort
BALLIGAND 5190 Jemeppe-sur-Sambre
TECHNO - HIGH - TECHNOLOGY 5032 Gembloux
NANOCYL 5060 Sambreville
R & O LAB 5030 Gembloux
CSP MEDICAL 5100 Namur
AXIMES 5101 Namur
Looking for more information about BIOXTRACT?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is BIOXTRACT still active? Yes. The Crossroads Bank for Enterprises lists BIOXTRACT as active.

What is the VAT number of BIOXTRACT? The VAT number of BIOXTRACT is BE 0480.174.942.

When was BIOXTRACT founded? BIOXTRACT was founded on 08-05-2003.

What is the address of BIOXTRACT? The current registered office of BIOXTRACT is Zone d'activités Nord 1, 5377 Somme-Leuze.

When did BIOXTRACT last file annual accounts? The latest annual accounts of BIOXTRACT were filed on 31-07-2026.

Does BIOXTRACT file its annual accounts on time? Yes. BIOXTRACT filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does BIOXTRACT have? BIOXTRACT employs 0.5 full-time equivalents according to its most recent annual accounts.

Is BIOXTRACT financially healthy? Addrly gives BIOXTRACT a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is BIOXTRACT profitable? The annual accounts of BIOXTRACT for 2025 show a profit of € 31 064.

What is the equity of BIOXTRACT? The equity of BIOXTRACT was € 1 054 700 at the close of the 2025 financial year.

Who are the directors of BIOXTRACT? The annual accounts of BIOXTRACT record 3 mandates. The names, roles and dates are visible with a free account.

Can BIOXTRACT receive Peppol e-invoices? Yes. BIOXTRACT is registered on the Peppol network and can receive structured electronic invoices.

What does BIOXTRACT do? The main activity of BIOXTRACT is: Scientific research and development.

Sources

How Addrly builds and refreshes this data